Response of Human-immunodeficiency-virus-associated Neurological Disease to 3'-azido-3'-deoxythymidine
Year: 1987
Type: article
Abstract: Four patients with human-immuno-deficiency-virus-associated neurological disease were treated with 3'-azido-3'-deoxythymidine (AZT). Three (two with chronic dementia, and one with chronic dementia and peripheral neuropathy) improved as assessed by clinical examination, psychometric tests, nerve conduction studies, and/or positron emission tomography; there was no improvement in the fourth patient who presented with paraplegia. These results support the hypothesis that certain AIDS-virus-associated neurological abnormalities are reversible by antiretroviral chemotherapy.
Source: The Lancet
Authors: Robert Yarchoan, Pim Brouwers, A. Robert Spitzer, Jordan Grafman, Bijan Safai, CarloF. Perno, StevenM. Larson, Gary Berg, MargaretA. Fischl, Alison Wichman, RoseV. Thomas, Arturo Brunetti, PeterJ. Schmidt, CharlesE. Myers, Samuel Broder
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $7,890
OpenAlex ID: W2122395850
